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Influenza vaccination coverage in the
geriatric population of the State of Geneva,
Switzerland
LAURENT GAUTHEY, LETIZ1A TOSCANI, ERIC CHAMOT, TANYA LAREQUI, CLAUDE FRANCOIS ROBERT •
Background: In Switzerland, every year the Federal Office of Public Health publishes recommendations for the use
of influenza vaccine In people over 65 years, patients of all ages suffering from chronic conditions or immuno-
suppression, families of the latter and health professionals. However, prior to the present study, there has been no
evaluation of the degree to which these recommendations are implemented. The purpose of the survey described
in this article was to evaluate flu vaccination coverage of the geriatric population living in the community, to obtain
qualitative information on the motivation for receiving vaccination and to understand the network of communication
on flu prevention. Methods: The study was performed on a random sample of 1,200 residents of the State of Geneva
aged 65 years or older. It involved a mail questionnaire and semi-structured telephone interviews on a subsample
of respondents. Results: The estimated vaccination coverage for 1994 was equal to 35.5% in persons 65 years-old
or older. Receiving information from a physician was the major determinant in the decision to be vaccinated.
Misconceptions about flu were common. Conclusions: The results of this study indicate that national re-
commendations concerning vaccination of elderly people are insufficiently observed in the State of Geneva. It is
necessary to reinforce preventive messages that explain why flu vaccination should be performed. These messages
should aim at correcting and completing elements of information already present in the at-risk population.
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Influenza is a major public health problem. Influenza epi-
demics are associated with significant increases in mor-
bidity, mortality and health costs, in particular among
people over 65 years, patients with chronic disease and
subjects with weakened immune defences.1"9
Immunization is effective in attenuating disease symp-
toms, as well as in reducing mortality and complications,
such as secondary bacterial infections of the respiratory
tract.10"1^ Although annual vaccination of die elderly is
recommended and has been found to be cost-effective,
the influenza vaccination coverage rates are low or un-
known in many industrialized countries.
In die USA, die US Department of Health and Human
Services established as a national objective for the year
2000 the attainment of a vaccination coverage against
influenza of at least 60% in people over 65 years and in
chronically ill patients.19"21 As a result of a national
programme, the influenza vaccination levels among
adults over 65 years of age increased substantially, rising
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from an estimated 32.9% in 198918 to 49.9% in 1993.22
The results of the Medicare Influenza Vaccination
Demonstration Project,23 which was launched in 1988, is
another example of what can be obtained through a
structured programme. By 1992, vaccination rates in the
2 million people to which the programme was addressed
increased from 26 to 51%. The multiple interventions of
this programme include health education through nurses,
physician prompts, chart reminders, patient letters and
mass-media messages.
To date there is no unified European strategy with respect
to influenza prevention. Most European countries have
developed national recommendations on influenza vac-
cination but few have national objectives and even fewer
have designed programmes to achieve these objectives.
In England, only an estimated 10-40% of high-risk pa-
tients are vaccinated annually. In contrast, coverage with
flu vaccination is high in France and Spain where yearly
national campaigns are organized to promote flu preven-
tion and influenza vaccination is reimbursed by the social
security for all elderly and high-risk people. In France,
vaccination coverage with flu vaccination increased be-
tween 1979 and 1991 from 30 to 74% in people over 70
years and from 7 to 19% in the adult population.24
Thus far, the number of doses of flu vaccine sold each year
has been the only available information on vaccination
practices in Switzerland. After a slow increase from 1984
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to 1992, the number of doses sold in Switzerland reached
a low 55 doses per 1,000 population in 1992.18Sixty doses
per 1,000 inhabitants were sold in 1993 and 65 doses per
1,000 in 1995. For comparison, vaccine distribution in
Spain, Italy and France increased from 40-50 doses per
1,000 population in 1984 to 175, 157 and 130 doses
respectively in 1992.18
Data on the doses of vaccine sold give no indication about
die level of protection of the population at risk. A study
carried out during winter 1989-1990 in nursing homes of
die Swiss canton of Ticino measured die vaccination
coverage to be 57% for bodi men and women in tiiis
population.25 On die basis of die number of doses of
vaccine distributed to residents in nursing homes, a sim-
ilar rate of vaccination is estimated for the canton of
Geneva. So far, however, vaccination coverage has never
been estimated in the elderly living in the community in
Switzerland.
Measures to promote flu prevention have been taken at
the federal and cantonal levels. Every year, the Swiss
Federal Office of Public Health publishes recommenda-
tions for the use of influenza vaccine in people over 65
years , patients of all ages suffering from chronic condi-
tions or immunosuppression, families of the latter and
healdi professionals.26 For the past 20 years, the Health
Department of Geneva State has reimbursed the doses of
influenza vaccine for elderly people and staff in geriatric
hospitals and in nursing homes. Furthermore, during the
autumns of 1993-1996 letters of information on flu vac-
cination were addressed to physicians, community nurses
and other concerned health professionals working in the
canton. Other actions followed in 1995 and 1996, in-
cluding the creation and diffusion of educational mater-
ial, media messages addressed to the general public and
information for health professionals via the Internet. In
other words, the present study took place in 1995 in the
context of a flu prevention campaign which has de-
veloped with increasing intensity in the State of Geneva,
starting in 1993. Other Swiss cantons joined in the effort
in 1996.
The purpose of our study was to estimate the vaccination
coverage of people over 65 years living in the community
of the canton of Geneva. Qualitative data was also col-
lected on the motivations for receiving or not receiving
vaccination and on the local network of communication
on flu prevention.
MATERIAL AND METHODS
A random sample of 1,200 residents of die State of
Geneva aged 65 years or older was obtained from the
Cantonal Population Office. A government decree al-
lowed the transfer of computerized data from the official
population register. The sample was stratified by sex and
age (groups 65—75 years, 76-85 years, 86 years or older)
with equal allocation. Data on age, sex, citizenship,
marital status, profession and county was also obtained
from the Cantonal Population Office.
In 1995, the population registry of the canton of Geneva
showed the total population to be 399,081 people, of
which 54,022 were over 65 years and, of these, 33,517
were women. Before the study, the sample size for each
sex and age group was calculated with die statcalc module
of the Epiinfo program for population surveys. A 50%
vaccination rate and a 50% response rate were assumed
for each group; the worst acceptable error was fixed at
±10% and the confidence level at 95% (95% CI from 40
to 60%). The real response rate varied for each group and
for each question but was always higher than 70% and the
vaccination coverage differed from 50%; as a result the
measured error in vaccination rate was in fact between
6.2 and 8.4% (confidence intervals are specified for each
result in tables 1, 2 and 3 and in the text).
The choice of the study design (mail survey) was the only
realistic option in the Swiss context. Most out-patient
care is delivered by free practitioners, who rarely compu-
terize patient files or vaccination records. Furthermore,
experience in the canton of Geneva shows that only a
small number of motivated practitioners will voluntarily
contribute data for a study.
In June 1995, an introduction letter from the State Health
Department, individually addressed and signed by two
physicians and a short questionnaire were mailed to all
subjects. The letter described the relevance and the ob-
jectives of the study. It emphasized the importance of a
high response rate while informing subjects of their right
to refuse to participate in the study. The questionnaire
collected data on whether respondents had been vaccin-
ated against flu during autumn 1994, whether they had
received vaccination in previous years and whedier they
intended to receive vaccination in the coming autumn.
Other questions assessed knowledge that vaccination was
indicated, sources of information on flu prevention and
the occurrence of flu-like episodes during the period
October 1994 to April 1995. A specific question allowed
participants to refuse telephone contact for the qualit-
ative interview.
Non-respondents received a second mailing after two
weeks. Follow-up phone calls were attempted after one
month if necessary.
A second step involved telephone interviews of those
who did not refuse to contribute further to the survey.
Semi-structured questions explored the network of in-
formation and die motivations to refuse or to accept
influenza vaccination. Estimations of the proportions and
95% confidence intervals under stratified random sam-
pling were computed according to Levy and Lemeshow.27
A ratio estimation procedure was used to compute es-
timations for subgroups.27
Vaccination rates were estimated by age, sex, national
origin, marital status, previous history of influenza im-
munization and intention to receive vaccination. Other
variables studied but not described in the present article
include professional category, flu-like episodes and neigh-
bourhood of residence.
The protocol was approved by the ethics committee of
the Institute of Social and Preventive Medicine of Ge-
neva University Medical Centre.
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RESULTS
Mail survey
Of the 1,200 people in the sample, 1,010 (84%) returned
the questionnaire. Five hundred and fifty-one completed
it after a second mailing and 223 after a telephone re-
minder. Of the 190 non-respondents, 106 had moved and
could not be located, 20 refused to participate, 17 were
travelling outside the canton and 11 had died or were
hospitalized.
The reported vaccination coverage of the Geneva popu-
lation over 65 years for 1994 was 35.5% (table I). There
is a significant increase in this reported vaccination
coverage from 1992 to 1994 (%2 test for trend, p<0.01).
In 1994, vaccination coverage was higher among males
than females (39.9 versus 32.7%, p=0.04). It increased
with age for both sexes (table 2). The difference between
men and women decreased with age and was no longer
significant for age groups 86 years and over. In this latter
category, the proportion of immunized subjects was sim-
ilar to that found in male and female residents of Geneva
nursing homes (unpublished data).
Vaccination coverage did not vary with ethnic origin. It
was equal to 37.4% among Geneva natives (95% CI:
29.5-43.5), 35.3% (95% CI: 26.0-44.6, p=0.73) among
people from other Swiss cantons and 32.8% (95% CI:
10.5-55.1, p°0.70) among foreigners. Vaccination
coverage was similar among married subjects (36.8%;
95% CI: 29.7^3.9) and widowed (40.2%; 95% CI: 2 9 3 -
51.0, p=0.61), separated or divorced (28.4%; 95% CI:
0.0-67.7, p=0.68), and single persons (27.7%; 95% CI:
0.0-62.4, p-0.62).
The information on indication to flu immunization
appeared adequate. Overall, 86.8% of the respondents
(95% CI: 83.0-90.6) knew they were members of the
target population for the vaccine. Although less often
immunized than men, women were more likely to be
aware of the recommendation (91.9 versus 86.8%,
p=0.04). This difference by
sex was observed across all
age groups (table 3).
The proportion of subjects
intending to receive vac-
cination in 1995 was equal to
52.4% (95% CI: 48.4-56.4).
For all sex and age groups,
this proportion was higher
than the 1994 immunization
rate but much lower than the
proportion of subjects aware
that vaccination was re-
commended to them (data
not shown). Attitudes to-
wards vaccination were pos-
itively related to past im-
munization, since 97.4% of
the individuals vaccinated in
1994 (95% CI: 95.4-99.4)
were planning to receive
I vaccination in 1995.
Telephone survey
Four hundred and seventy respondents to the mail ques-
tionnaire accepted die telephone survey. Reliable inter-
views were obtained from 324 (69%) of them.
As compared with respondents to the mail questionnaire
who refused die telephone interview, the participants to
die phone survey were younger (mean age 7 7.4 versus 80.5
years, p<0.0001), more likely to be male (56.5 versus
47.6%, p=0.006), more likely to know that vaccination
was indicated (93.4 versus 88.0%, p=0.01), and more
likely to have been immunized against flu in 1994 (48.7
versus 41.1%, p=0.03).
Because of die low participation rate (27%), die results
of die telephone survey were considered as merely
qualitative.
Of the 153 subjects who had reported vaccination in 1994
in the mail survey, nine (6%) declared during the phone
interview that immunization was not by injection. The
drugs received included 'homeopathic vaccination'.
Physicians appeared as the major source of information
and motivation on vaccination (table 4). The media was
also an important source of information but apparently
contributed little to the motivation for vaccination.
Respondents who were not immunized against flu in 1994
(n=161) spontaneously expressed various reasons for
having refused vaccination. Many subjects had not sought
Table 1 Vaccination coverage by year
Year
Vaccination coverage
% (95% CI)"
1992
1993
1994
27.5
29.7
35.5
(24.8-30.2)
(27.0-32.4)
(32.2-38.8)
a: These vaccination coverages are calculated for the population of the
canton, weighed for each sex and age group In each given year
Table 2 Vaccination coverage in 1994 by sex and age group
Age group
(years)
65-75
76-85
86-95
Men vaccinated
n(N) % (95% CD"
58(172)
84(165)
87(148)
33.7 (26.7-41.3)
50.9 (43.0-58.8)
58.8 (50.4-66.8)
Women vaccinated
n (N) % (95% CD"
39(171)
61(147)
86(149)
22.8
41.5
57.7
(16.7-29.8)
(33.4-49.9)
(49.7-65.5)
a: The percentages arc calculated by dividing the people that gave a positive answer by the total number of people
having answered the specific question, for each subgroup by age and sex.
Table 3 People aware that vaccination U recommendec
Age group
(years)
65-75
76-85
86-95
n(N)
140(165)
149(162)
121 (143)
Men
%
84.9
92.0
84.6
(95% CI)"
(78.5-90.0)
(86.7-95.7)
(77.6-90.1)
1 to them by sex and age group
n(N)
152(168)
147 (156)
147 (156)
Women
%
90.5
94.2
93.0
(95% CD"
(85.0-94.5)
(89.3-97.3)
(87.4-96.4)
a: The percentages arc calculated by dividing the people that gave a positive answer by the total number of people
havmg answered the specific question, for each subgroup by age and sex.
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vaccination either because they 'rarely had flu' (66.5%),
because they 'were in good health' (62.7%), or because
they 'did not fear flu' (46.6%). Less often subjects reported
that 'immunization was not recommended by their physi-
cians' (21.7%), that they 'feared vaccination side effects'
(11.8%), that they had 'a history of negative vaccination
effects' (10.6%), or that they 'doubted that the vaccine
was effective' (9.3%).
DISCUSSION
The high response rate to the mail questionnaire con-
firmed that the design of the study is well adapted to the
context of the canton of Geneva. The response rate
appears to reflect the respect for official institutions of the
elderly population.
National recommendations concerning the vaccination
of elderly people are insufficiently implemented in die
State of Geneva. The estimation of vaccination coverage
for 1994 in persons 65 years-old or older was only 35.5%.
Moreover, it is likely that the true vaccination coverage
in this population was even lower. Some subjects classi-
fied as immunized apparently received homeopathic pre-
parations or other drugs instead of the true vaccine. It is
also likely that vaccination was even less common in
non-respondents than in respondents. The national situ-
ation is probably similar or less favourable, given the
influence on the Geneva population of nearby France and
an active policy of information of the local health au-
thority since 1993.
The great majority of elderly people are aware that flu
vaccination is recommended to them. However, their
information is superficial, they have little knowledge of
the potential harmful effects of flu and have a series of
fears and misconceptions about vaccination. Health pro-
fessionals other than physicians do not appear to con-
tribute to a relevant extent to the diffusion of information
in the target population.
Some improvement in coverage is expected widi the
introduction of flu vaccination in the list of preventive
measures reimbursed by health insurance, as of 1996. It is,
however, interesting to note that the vaccination cover-
age in the older age groups (86 years and over) living in
Table 4 Sources of information and of motivation for vaccination
(N=314a)
Source
Physician
Pharmacist
Nurse
Family
Friends
Media in general
Television
Radio
Newspapers
Unvaccinated %
N=161
26.7
3.1
0.6
11.2
32.3
23.6
9.9
14.9
37.9
a: Vaccination status was unknown for ten subjects.
Vaccinated %
N-153
90.2
2.0
2.0
11.1
17.6
23.5
13.1
14.4
32.7
die community is similar to that of residents of nursing
homes who predominantly belong to the same age group.
As vaccine was free of cost in nursing homes but not for
people living in the community, this would indicate that
cost has not been a determinant barrier to vaccination.
Note that vaccine supply has not been a limiting factor
for vaccination of high-risk groups in the canton of
Geneva. Three competing companies commercialize flu
vaccine and this is distributed to people living in the
community through private channels (pharmacies and
physicians in free practice). To our knowledge occasional
shortages in supply have never affected all three brands at
the same time and have only lasted 2-3 days.
The results of this study indicate that it is necessary to
reinforce preventive messages that explain why flu vac-
cination should be performed. These messages should aim
at correcting and completing elements of information
already present in the at-risk population. Furthermore,
health professionals in close contact with elderly people,
in particular nurses, should be prime targets of training
activities aimed at increasing tlieir involvement in in-
formation campaigns. The relative importance of factors
other than information that may limit access to vaccina-
tion should be studied and addressed.
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